The following discussion highlights the current operating environment and
summarizes the financial position of Core Laboratories N.V. and its subsidiaries
as of March 31, 2023, and should be read in conjunction with (i) the unaudited
interim consolidated financial statements and notes thereto included elsewhere
in this Quarterly Report and (ii) the audited consolidated financial statements
and accompanying notes to our 2022 Annual Report.

General

Core Laboratories N.V. is a Netherlands limited liability company. It was
established in 1936 and is one of the world's leading providers of proprietary
and patented reservoir description and production enhancement services and
products to the oil and gas industry. These services and products can enable our
clients to evaluate and improve reservoir performance and increase oil and gas
recovery from new and existing fields. Core Laboratories N.V. has over 70
offices in more than 50 countries and employs approximately 3,600 people
worldwide.

References to "Core Lab", "Core Laboratories", the "Company", "we", "our" and similar phrases are used throughout this Quarterly Report and relate collectively to Core Laboratories N.V. and its consolidated affiliates.



We operate our business in two segments: Reservoir Description and Production
Enhancement. These complementary operating segments provide different services
and products and utilize different technologies for evaluating and improving
reservoir performance and increasing oil and gas recovery from new and existing
fields.


Reservoir Description: Encompasses the characterization of petroleum reservoir
rock and reservoir fluids samples to increase production and improve recovery of
crude oil and natural gas from our clients' reservoirs. We provide
laboratory-based analytical and field services to characterize properties of
crude oil and crude oil-derived products to the oil and gas industry. We also
provide proprietary and joint industry studies based on these types of analyses
and manufacture associated laboratory equipment. In addition, we provide
reservoir description capabilities that support various activities associated
with energy transition projects, including services that support carbon capture,
utilization and storage, hydrogen storage, geothermal projects, and the
evaluation and appraisal of mining activities around lithium and other elements
necessary for energy storage.


Production Enhancement: Includes services and manufactured products associated
with reservoir well completions, perforations, stimulation, production and well
abandonment. We provide integrated diagnostic services to evaluate and monitor
the effectiveness of well completions and to develop solutions aimed at
increasing the effectiveness of enhanced oil recovery projects.

On January 17, 2023, the Company filed a proxy statement/prospectus announcing
its intention to reorganize the Company's corporate structure, which will
include redomestication (the "Redomestication") of the parent company from the
Netherlands to the United States as Core Laboratories Inc., a Delaware
corporation. The Company and its Board of Supervisory Directors believes that
the Redomestication will enhance shareholder value over the long-term through
simplifying the corporate structure, improving operational efficiencies and
reducing administrative costs.

The Redomestication requires a shareholder vote for approval, which was
conducted through an extraordinary general meeting of the Company's shareholders
on March 29, 2023, and received an affirmative vote. The transaction is expected
to become effective approximately 30 days following the date of the
extraordinary general meeting, on May 1, 2023.

See Note 1 - Description of Business of the Notes to the Interim Consolidated Financial Statements for further details.

Cautionary Statement Regarding Forward-Looking Statements



This Quarterly Report contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act.
Certain statements contained in this Management's Discussion and Analysis of
Financial

                                       19
                                                               Return to Index

--------------------------------------------------------------------------------




Condition and Results of Operations section, including those under the headings
"Outlook" and "Liquidity and Capital Resources", and in other parts of this
Quarterly Report, are forward-looking. In addition, from time to time, we may
publish forward-looking statements relating to such matters as anticipated
financial performance, business prospects, technological developments, new
products, research and development activities and similar matters.
Forward-looking statements can be identified by the use of forward-looking
terminology such as "may", "will", "believe", "expect", "anticipate",
"estimate", "continue", or other similar words, including statements as to the
intent, belief, or current expectations of our directors, officers, and
management with respect to our future operations, performance, or positions or
which contain other forward-looking information. These forward-looking
statements are based on our current expectations and beliefs concerning future
developments and their potential effect on us. While management believes that
these forward-looking statements are reasonable as and when made, no assurances
can be given that the future results indicated, whether expressed or implied,
will be achieved. While we believe that these statements are and will be
accurate, our actual results and experience may differ materially from the
anticipated results or other expectations expressed in our statements due to a
variety of risks and uncertainties.

We undertake no obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise.
For a more detailed discussion of some of the foregoing risks and uncertainties,
see Part II, "Item 1A - Risk Factors" of this Quarterly Report and "Item 1A -
Risk Factors" in our 2022 Annual Report and other reports filed by us with the
SEC.

Outlook

Currently, global oil inventories are low relative to historical levels and
supply from OPEC+ and other oil producing nations are not expected to be
sufficient to meet forecasted oil demand growth for the next few years. In
October 2022, OPEC+ determined to reduce production beginning in November 2022
through December 2023 by 2 million bbls per day, due to the uncertainty
surrounding the global economic and oil market outlooks. On April 2, 2023, OPEC+
announced further reductions in production of around 1.16 million bbls per day
in addition to the October 2022 reductions as a precautionary measure aimed at
supporting the stability of the oil market. The current global demand for crude
oil and natural gas remains at a high level and according to the latest
International Energy Agency's report, global demand is expected to increase
throughout 2023. As a result, it is anticipated that crude-oil commodity prices
for the near-term will remain at current levels or increase if projections for
demand remain accurate. In 2022, capital spending towards the exploration of
crude oil and natural gas reached their highest level in over a decade, and our
clients' activities associated with the appraisal, development and production of
crude oil and natural gas are also expected to increase for the remainder of
2023. However, we believe some oil and gas operators will continue to manage
their capital spending within free cash flow and maintain their focus on
improving and maintaining a stronger balance sheet, which also is expected to
moderate future growth in activities associated with the production of oil and
gas.

The geopolitical conflict between Russia and Ukraine that erupted in February
2022, caused disruptions to traditional maritime supply chains associated with
the movement of crude oil, primarily reducing the level of crude oil sourced
from Russia and being imported into various European ports. The disruptions to
traditional maritime supply chains of crude oil and derived products, such as
diesel fuel, and associated sanctions imposed on maritime exports of these
products out of Russia, also caused significant volatility in both the prices
and trading patterns of these products during 2022 and into 2023. The average
crude-oil prices for the first quarter of 2023 were significantly lower compared
to the average prices for 2022, however, crude-oil prices still remain elevated
when compared to 2021, prior to the Russia-Ukraine conflict.

The maritime supply chains associated with the movement of crude oil continue to
realign and establish new logistical and trading patterns, as Europe finds new
suppliers of crude oil to import into the region, and maritime exports from
Russia find new destinations. Thus, Core Lab expects supply lines to continue to
realign, and the Company's volume of associated laboratory services to increase
commensurate with the trading and movement of crude-oil into Europe and across
the globe. The situation continues to evolve and the United States, the European
Union, the United Kingdom and other countries may implement additional
sanctions, export controls or other measures against Russia, Belarus and other
countries, regions, officials, individuals or industries in the respective
territories. We have no way to predict the progress or outcome of the

                                       20
                                                               Return to 

Index

--------------------------------------------------------------------------------

conflict in Ukraine or its impacts in Ukraine, Russia or Belarus as the conflict, and any resulting government responses, are fluid and beyond our control.



Our major clients continue to focus on capital management, return on invested
capital, free cash flow, and returning capital to their shareholders, as opposed
to a focus on production growth. The companies adopting value versus volume
metrics tend to be the more technologically sophisticated operators and form the
foundation of Core Lab's worldwide client base. As oil and gas commodity prices
have stabilized or are expected to increase in the near to mid-term, the Company
expects our clients' activities associated with increasing oil and gas reserves
and production levels will continue to increase in the coming years.
Additionally, some of our major clients have begun investing in projects to
reduce the levels of CO2 in the atmosphere, including carbon capture and
sequestration projects. The Company's activities on these projects increased
significantly in 2022 and is expected to continue expanding in 2023 and beyond.

As part of our long-term growth strategy, we continue to expand our market
presence by opening or expanding facilities in strategic areas and optimizing
our global network to be aligned with client demand and market conditions. More
recently, we have expanded our laboratory capabilities in Qatar, Saudi Arabia
and Brazil, but have consolidated facilities in the United States and Canada. We
believe our market presence in strategic areas provides us a unique opportunity
to serve our clients who have global operations, whether they are international
oil companies, national oil companies, or independent oil companies.

Results of Operations
Our results of operations as a percentage of applicable revenue are as follows
(in thousands):

                                        Three Months Ended March 31,                   Change
                                        2023                    2022               $            %
REVENUE:
Services                        $  91,076       71%     $  84,723       73%     $  6,353       7%
Product sales                      37,280       29%        30,577       27%        6,703       22%
Total revenue                     128,356      100%       115,300      100%       13,056       11%
OPERATING EXPENSES:
Cost of services, exclusive
of depreciation expense shown
below*                             70,934       78%        68,857       81%        2,077       3%
Cost of product sales,
exclusive of depreciation
expense shown below*               30,594       82%        28,095       92%        2,499       9%
Total cost of services and
product sales                     101,528       79%        96,952       84%        4,576       5%
General and administrative
expense, exclusive of
depreciation expense shown
below                              16,331       13%        12,545       11%        3,786       30%
Depreciation and amortization       4,044       3%          4,557       4%          (513 )    (11)%
Other (income) expense, net           (28 )     -%          1,637       1%        (1,665 )     NM
OPERATING INCOME (LOSS)             6,481       5%           (391 )     -%         6,872       NM
Interest expense                    3,429       3%          2,644       2%           785       30%
Income (loss) before income
taxes                               3,052       2%         (3,035 )    (3)%        6,087       NM
Income tax expense (benefit)          610       -%         (1,196 )    (1)%        1,806       NM
Net income (loss)                   2,442       2%         (1,839 )    (2)%        4,281       NM
Net income (loss)
attributable to
non-controlling interest               69       -%             49       -%            20       NM
Net income (loss)
attributable to Core
Laboratories N.V.               $   2,373       2%      $  (1,888 )    (2)%     $  4,261       NM

Other Data:
Current ratio (1)                  2.38:1                  2.03:1
Debt to EBITDA ratio (2)           2.52:1                  3.08:1
Debt to Adjusted EBITDA            2.18:1                  2.23:1
ratio (3)



"NM" means not meaningful
*Percentage based on applicable revenue rather than total revenue

                                       21
                                                               Return to 

Index

--------------------------------------------------------------------------------

(1)


Current ratio is calculated as follows: current assets divided by current
liabilities.
(2)
Debt to EBITDA ratio is calculated as follows: debt less cash divided by the sum
of consolidated net income plus interest, taxes, depreciation, amortization and
certain non-cash adjustments.
(3)
Debt to Adjusted EBITDA ratio (as defined in our Credit Facility) is calculated
as follows: debt less cash divided by the sum of consolidated net income plus
interest, taxes, depreciation, amortization, impairments, severance and certain
non-cash adjustments.

                                               Three Months Ended                         Change
                                   March 31, 2023          December 31, 2022          $            %
REVENUE:
Services                        $  91,076       71%     $     88,938       70%     $  2,138       2%
Product sales                      37,280       29%           38,633       30%       (1,353 )    (4)%
Total revenue                     128,356      100%          127,571      100%          785       1%
OPERATING EXPENSES:
Cost of services, exclusive
of depreciation expense shown
below*                             70,934       78%           69,656       78%        1,278       2%
Cost of product sales,
exclusive of depreciation
expense shown below*               30,594       82%           30,160       78%          434       1%
Total cost of services and
product sales                     101,528       79%           99,816       78%        1,712       2%
General and administrative
expense, exclusive of
depreciation expense shown
below                              16,331       13%            8,724       7%         7,607       87%
Depreciation and amortization       4,044       3%             4,073       3%           (29 )    (1)%
Other (income) expense, net           (28 )     -%              (660 )    (1)%          632      (96)%
OPERATING INCOME (LOSS)             6,481       5%            15,618       12%       (9,137 )    (59)%
Interest expense                    3,429       3%             3,081       2%           348       11%
Income (loss) before income
taxes                               3,052       2%            12,537       10%       (9,485 )    (76)%
Income tax expense (benefit)          610       -%             5,847       5%        (5,237 )    (90)%
Net income (loss)                   2,442       2%             6,690       5%        (4,248 )    (63)%
Net income (loss)
attributable to
non-controlling interest               69       -%               (61 )     -%           130       NM
Net income (loss)
attributable to Core
Laboratories N.V.               $   2,373       2%      $      6,751       5%      $ (4,378 )    (65)%

Other Data:
Current ratio (1)                  2.38:1                     2.05:1
Debt to EBITDA ratio (2)           2.52:1                     2.68:1
Debt to Adjusted EBITDA            2.18:1                     2.29:1
ratio (3)



"NM" means not meaningful
*Percentage based on applicable revenue rather than total revenue
(1)
Current ratio is calculated as follows: current assets divided by current
liabilities.
(2)
Debt to EBITDA ratio is calculated as follows: debt less cash divided by the sum
of consolidated net income plus interest, taxes, depreciation and amortization
and certain non-cash adjustments.
(3)
Debt to Adjusted EBITDA ratio (as defined in our Credit Facility) is calculated
as follows: debt less cash divided by the sum of consolidated net income plus
interest, taxes, depreciation, amortization, impairments, severance and certain
non-cash adjustments.

Operating Results for the Three Months Ended March 31, 2023 compared to the Three Months Ended March 31, 2022 and December 31, 2022

Service Revenue



Service revenue is primarily tied to activities associated with the exploration,
appraisal, development, and production of oil, gas and derived products outside
the U.S. For the three months ended March 31, 2023, service revenue was $91.1
million, an increase of 7% year-over-year and 2% sequentially. Year-over-year,
the increase was due to slight growth in activity levels in

                                       22
                                                               Return to 

Index

--------------------------------------------------------------------------------




international markets, which continued to be impacted by the Russia-Ukraine
geopolitical conflict, coupled with a moderate increase in activity levels in
the U.S. market. Sequentially, the Company would normally experience a seasonal
decline in international activity, however, activity levels were relatively flat
in international markets as supply chains have stabilized in Europe, activity on
international projects has improved, and activity levels in the U.S. increased
moderately.

We continue to focus on large-scale core analyses and reservoir fluids
characterization studies in the Eagle Ford, the Permian Basin and the Gulf of
Mexico, along with Guyana, Suriname, Malaysia and other international locations
such as offshore South America, Australia, Southern Namibia and the Middle East,
including Kuwait and the United Arab Emirates. Analysis of crude oil derived
products also occurs in every major producing region of the world.

Product Sales Revenue



For the three months ended March 31, 2023, product sales revenue of $37.3
million increased 22% year-over-year and decreased 4% sequentially. Rig count is
one indicator of activity levels associated with the exploration and production
of oil and gas. The average rig count for U.S. land increased over 20%
year-over-year and decreased 2% sequentially. The growth in U.S. land activity
levels was softened by a significant decrease in natural gas commodity prices,
which began to weaken sharply in December 2022. The average rig count for
international markets increased 11% year-over-year and 1% sequentially.
Year-over-year our product sales revenue increased by 15% in the U.S. market and
28% in the international markets, as a result of the increased drilling
activity. Sequentially, our product sales revenue in the U.S. market increased
approximately 3% as a result of the increased activity, outperforming the
average rig count and estimated well completion activity; however, product sales
revenue in the international markets decreased by approximately 8% due to a
lower level of large bulk orders completed in the three months ended March 31,
2023.

Cost of Services, excluding depreciation



Cost of services was $70.9 million for the three months ended March 31, 2023, an
increase of 3% year-over-year and 2% sequentially. Cost of services expressed as
a percentage of service revenue decreased to 78% for the three months ended
March 31, 2023, compared to 81% for the same period in the prior year, and
remained flat compared to the prior quarter. The year-over-year improvement in
cost of services as a percentage of service revenue for the three months ended
March 31, 2023, was primarily associated with improved utilization of our global
laboratory network on higher revenue.

Cost of Product Sales, excluding depreciation



Cost of product sales was $30.6 million for the three months ended March 31,
2023, an increase of 9% year-over-year and 1% sequentially. Cost of product
sales expressed as a percentage of product sales revenue was 82% for the three
months ended March 31, 2023, compared to 92% for the same period in the prior
year, and 78% for the prior quarter. Year-over-year, the lower cost of product
sales as a percentage of product sales revenue was primarily due to improved
manufacturing productivity and absorption of fixed costs on a higher revenue
base. Sequentially, the higher cost of product sales as a percentage of product
sales revenue was primarily due to higher inflation which has increased our
shipping and raw materials costs, and a slight decrease in manufacturing
productivity.

General and Administrative Expense, excluding depreciation



General and administrative ("G&A") expense includes corporate management and
centralized administrative services that benefit our operations. G&A expense for
the three months ended March 31, 2023 was $16.3 million, an increase of $3.8
million year-over-year and $7.6 million sequentially. The variances across these
three quarters are primarily due to adjustments in the recognition of
stock-based compensation expense during those periods. The three months ended
March 31, 2023 includes a charge of $6.5 million to recognize accelerated stock
compensation expense recorded for retirement eligible employees compared to a
charge of $3.9 million for the same quarter in the prior year. The three months
ended December 31, 2022 includes the reversal of $1.9 million in stock
compensation expense previously recognized, to align and revalue the
compensation expense with the vesting level of performance share awards.

                                       23
                                                               Return to 

Index

--------------------------------------------------------------------------------

Depreciation and Amortization Expense



Depreciation and amortization expense for the three months ended March 31, 2023,
was $4.0 million a decrease of 11% year-over-year and relatively flat
sequentially. Year-over-year, the decrease in depreciation and amortization
expense was primarily due to more assets that became fully depreciated compared
to additional capital expenditures.

Other (Income) Expense, Net



The components of other (income) expense, net, are as follows (in thousands):

                                                     Three Months Ended
                                                          March 31,
                                                      2023          2022
(Gain) loss on sale of assets                      $       96      $  (157 )
Results of non-consolidated subsidiaries                 (137 )        (93 )
Foreign exchange (gain) loss, net                        (144 )       (417 )
Rents and royalties                                      (145 )       (171 )

Return on pension assets and other pension costs (326 ) (145 ) Loss on lease abandonment and other exit costs

            641            -
Assets write-down                                       1,015            -
Severance and other charges                                 -        3,332
Insurance and other settlements                          (604 )       (669 )
Other, net                                               (424 )        (43 )
Total other (income) expense, net                  $      (28 )    $ 1,637


During the three months ended March 31, 2023, we abandoned certain leases in the
U.S. and Canada and incurred costs of $0.6 million. We integrated and relocated
certain of our facilities in Canada and wrote down related leasehold
improvements and right of use assets of $1.0 million.

For the three months ended March 31, 2023, the State of Louisiana expropriated
the access road to one of our facilities and paid us a settlement of $0.6
million. During the three months ended March 31, 2022, we received insurance
settlement of $0.7 million associated with business interruptions and property
losses to certain facilities caused by the North America mid-continent winter
storm in February 2021.

Foreign exchange (gain) loss, net by currency is summarized in the following
table (in thousands):

                                      Three Months Ended
                                           March 31,
                                      2023           2022
British Pound                       $    (251 )     $   (36 )
Canadian Dollar                            58            73
Colombian Peso                             53            98
Euro                                       84           (98 )
Russian Ruble                            (251 )        (602 )
Other currencies, net                     163           148

Foreign exchange (gain) loss, net $ (144 ) $ (417 )

Interest Expense



Interest expense for the three months ended March 31, 2023 was $3.4 million
compared to $2.6 million and $3.1 million for the three months ended March 31,
2022 and December 31, 2022, respectively. The variances are primarily associated
with higher interest rates on our aggregated variable rate debt in the
respective quarters.

                                       24
                                                               Return to Index

--------------------------------------------------------------------------------

Income Tax Expense (Benefit)



The Company recorded an income tax expense of $0.6 million and income tax
benefit of $1.2 million for the three months ended March 31, 2023 and 2022,
respectively. The effective tax rate for the three months ended March 31, 2023
was 20.0%. The effective tax rate for the three months ended March 31, 2022 was
39.4%. The tax rate for the three months ended March 31, 2022, was largely
impacted by the release of withholding tax related to unrepatriated earnings of
our Russian subsidiary, which are not expected to be distributed in the
foreseeable future.

© Edgar Online, source Glimpses